Clinical Trial Update: NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases [Phase 2]

View source ↗

Summary

Phase 2 trial update on NK cell–based non-myeloablative transplantation for acute myeloid diseases, including acute myeloid leukemia and myelodysplastic syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2019-12-16